 FORT WORTH, Texas, May 20, 2022 GLOBE NEWSWIRE -- TFF Pharmaceuticals, Inc. NASDAQ: TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform, today announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022. Company management will also be participating in virtual one-on-one meetings throughout the conference. 